Sign Up Today and Learn More About Reprieve Cardiovascular Stock
Invest in or calculate the value of your shares in Reprieve Cardiovascular or other pre-IPO companies through EquityZen's platform.
Reprieve Cardiovascular Stock
Reprieve Cardiovascular is focused on improving outcomes for patients suffering from acute decompensated heart failure.
About Reprieve Cardiovascular Stock
Founded
2018
Headquarters
Milford, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Reprieve Cardiovascular Press Mentions
Stay in the know about the latest news on Reprieve Cardiovascular
Reprieve Cardiovascular to Present at the 37th Annual Piper Sandler Healthcare Conference
businesswire • Nov 25, 2025
Lightstone Ventures Marks Year-to-Date 2025 Milestones for its Innovative Biotech and Medtech Portfolio Companies
citybiz • Sep 25, 2025
Lightstone Ventures Marks Year-to-Date 2025 Milestones for its Innovative Biotech and Medtech Portfolio Companies
prnewswire • Sep 24, 2025
Reprieve Cardiovascular Attracts New Funding, Begins Study Enrollment
mpo-mag • Aug 27, 2025
Reprieve Cardiovascular Banks $61M in Series B
vcnewsdaily • Aug 19, 2025
Reprieve Cardiovascular Management
Leadership team at Reprieve Cardiovascular
Board Member
Ethan Benovitz
Managing Director and Chief Financial Officer
Greg Mann
Join now and verify your accreditation status to gain access to:
- Reprieve Cardiovascular Current Valuation
- Reprieve Cardiovascular Stock Price
- Reprieve Cardiovascular Management
- Available deals in Reprieve Cardiovascular and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Reprieve Cardiovascular Cap Table and Funding History by Share Class and Liquidity Preferences
- Reprieve Cardiovascular Revenue and Financials
- Reprieve Cardiovascular Highlights
- Reprieve Cardiovascular Business Model
- Reprieve Cardiovascular Risk Factors
- Reprieve Cardiovascular Research Report from SACRA Research
Trading Reprieve Cardiovascular Stock
How to invest in Reprieve Cardiovascular stock?
Accredited investors can buy pre-IPO stock in companies like Reprieve Cardiovascular through EquityZen funds. These investments are made available by existing Reprieve Cardiovascular shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Reprieve Cardiovascular stock?
Shareholders can sell their Reprieve Cardiovascular stock through EquityZen's private company marketplace. EquityZen's network includes over 430K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."